sterculia (OTC)

Brand and Other Names:
  • Print

Dosing & Uses

AdultPediatric

Dosage Forms & Strengths

granules

  • 62% sterculia gum

Constipation

1-2 sachets PO qD-BID; place granules on tongue & swallow with 250 mL of water

Dosage Forms & Strengths

granules

  • 62% sterculia gum

Constipation

>12 years old: same as adult dose

<12 years old: not established

Next:

Interactions

Interaction Checker

and sterculia

No Results

     activity indicator 
    No Interactions Found
    Interactions Found

    Contraindicated

      Serious - Use Alternative

        Significant - Monitor Closely

          Minor

            All Interactions Sort By:
             activity indicator 

            Contraindicated (0)

              Serious - Use Alternative (0)

                Monitor Closely (1)

                • deflazacort

                  sterculia and deflazacort both decrease serum potassium. Use Caution/Monitor.

                Minor (1)

                • sodium picosulfate

                  sterculia decreases effects of sodium picosulfate by Mechanism: unspecified interaction mechanism. Minor/Significance Unknown.

                Previous
                Next:

                Adverse Effects

                Frequency Not Defined

                Constipation

                Flatulence

                Abdominal cramping

                Impaction

                Previous
                Next:

                Warnings

                Contraindications

                Hypersensitivity, obstruction, fecal impaction, symptoms of appendicitis or acute surgical abdomen, GI ulceration, dysphagia, rectal bleeding

                Cautions

                Ingest adequate quantities of water with the preparation

                Not recommended during abdominal pain, nausea/vomiting, fever

                Separate by all other medications by 2 hr, since laxatives may decrease absorption

                Previous
                Next:

                Pregnancy & Lactation

                Pregnancy Category: N/A

                Lactation: no data available; not absorbed, therefore unlikely to pose risk in breast-feeding

                Pregnancy Categories

                A: Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.

                B: May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk.

                C: Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done.

                D: Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk.

                X: Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist.

                NA: Information not available.

                Previous
                Next:

                Pharmacology

                Onset: 12-72 hr

                Metabolism: not absorbed from GI tract

                Excretion: fecal

                Mechanism of Action

                Sterculia urens gum; bulk-producing laxative

                Previous
                Next:

                Images

                No images available for this drug.
                Previous
                Next:

                Patient Handout

                A Patient Handout is not currently available for this monograph.
                Previous
                Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.